# Evaluating the Impact of SomaSignal Tests on Medical Management and Change in Risk in Patients at Higher Risk of Cardiovascular Disease: A Feasibility and an Adaptive Implementation Study

> **NCT04836117** · NA · TERMINATED · sponsor: **Intermountain Health Care, Inc.** · enrollment: 12 (actual)

## Conditions studied

- Health Behavior

## Interventions

- **OTHER:** SomaSignal Test Results

## Key facts

- **NCT ID:** NCT04836117
- **Lead sponsor:** Intermountain Health Care, Inc.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-08-12
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** 12 patients were enrolled to determine feasibility. It was mutually agreed that there was low feasibility and not to proceed with the larger study.
- **Last updated:** 2026-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04836117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04836117, "Evaluating the Impact of SomaSignal Tests on Medical Management and Change in Risk in Patients at Higher Risk of Cardiovascular Disease: A Feasibility and an Adaptive Implementation Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04836117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*